Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Spermosens Logo
Spermosens Growth Score
94
CB Rank
6789
Heat Score
78
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor infertility.
Founded
obfuscation
PublicPost-IPO Debt Lund, Skane Lan, Sweden1-10 www.spermosens.com/
Fertility
Health Care
Health Diagnostics
Manufacturing
Medical Device
Overview

Spermosens
Total Funding
obfuscation
Growth Score
94
Heat Score
78

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score94
-3 pts
in past quarter
Heat Score 78
11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Spermosens

CB Rank
6789
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor infertility.
Founded
obfuscation
PublicPost-IPO Debt Lund, Skane Lan, Sweden1-10 www.spermosens.com/
Fertility
Health Care
Health Diagnostics
Manufacturing
Medical Device

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Spermosens AB
Operating Status Active
Stock Symbol  FRA:9R5
Company Type For Profit
Phone Number +46-0103 300 442
Contact Email info@spermosens.com
Predictions & Insights

Growth Insight

See this Growth Insight
Spermosens is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

JUNO-Checked
A diagnostic system that predicts sperm fertilization capacity by measuring sperm binding to egg cell proteins, aiding IVF treatment decisions.
JUNO-Checked Generation 3
A third-generation diagnostic system for functional testing in male fertility assessment for routine use in high-volume clinical laboratories.

Research & Development

Spermosens is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Spermosens Logo
Post-IPO Debt - Spermosens
—
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Mount Nebo Capital Logo
Mount Nebo Capital
—
Post-IPO Equity - Spermosens Logo
Post-IPO Equity - Spermosens
—
Mount Nebo Capital Logo
Mount Nebo Capital
—
Post-IPO Equity - Spermosens Logo
Post-IPO Equity - Spermosens
—
Mount Nebo Capital Logo
Mount Nebo Capital
—
Post-IPO Equity - Spermosens Logo
Post-IPO Equity - Spermosens
—
Mount Nebo Capital Logo
Mount Nebo Capital
—
Post-IPO Equity - Spermosens Logo
Post-IPO Equity - Spermosens
—
Mount Nebo Capital Logo
Mount Nebo Capital
—
Post-IPO Equity - Spermosens Logo
Post-IPO Equity - Spermosens
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 2

Employee Profiles

News

News and Press

News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

3,519
423.66%
 in past month

IT Spend

$91.7KThis year, Spermosens is projected to spend $91.7K on IT, according to Aberdeen.

Active Website Tech Count

7Spermosens is actively using 7 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.

Total IP

7The intellectual property of Spermosens includes 3 registered patents primarily in the 'Testing' category, according to IPqwery. Additionally, Spermosens has registered 4 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Spermosens's headquarters? Spermosens is located in Lund, Skane Lan, Sweden.Who invested in Spermosens? Spermosens has 3 investors including Mount Nebo Capital and  Mount Nebo Capital.When was the last funding round for Spermosens? Spermosens closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Spermosens's competitors? Alternatives and possible competitors to Spermosens may include Jack Fertility, Vitrolife, and  ExSeed Health.How much funding has Spermosens raised to date? Spermosens has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|